BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24851076)

  • 1. Unsupported conclusions in the article "Synephrine-containing dietary supplement precipitating apical ballooning syndrome in a young female".
    Stohs SJ
    Korean J Intern Med; 2014 May; 29(3):388-92. PubMed ID: 24851076
    [No Abstract]   [Full Text] [Related]  

  • 2. Synephrine-containing dietary supplement precipitating apical ballooning syndrome in a young female.
    Chung H; Kwon SW; Kim TH; Yoon JH; Ma DW; Park YM; Hong BK
    Korean J Intern Med; 2013 May; 28(3):356-60. PubMed ID: 23682231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions.
    Jordan S; Murty M; Pilon K
    CMAJ; 2004 Oct; 171(8):993-4. PubMed ID: 15497209
    [No Abstract]   [Full Text] [Related]  

  • 4. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synephrine: from trace concentrations to massive consumption in weight-loss.
    Stohs SJ
    Food Chem Toxicol; 2011 Jun; 49(6):1472-3; author reply 1474-5. PubMed ID: 21439342
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of evidence that p-synephrine is responsible for STEMI.
    Stohs SJ
    Tex Heart Inst J; 2010; 37(3):383; author reply 383-4. PubMed ID: 20548833
    [No Abstract]   [Full Text] [Related]  

  • 7. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
    Perova IB; Eller KI; Musatov AV; Tymolskaya EV
    Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Published Bitter Orange Extract and
    Stohs SJ; Ray SD
    J Diet Suppl; 2020; 17(3):355-363. PubMed ID: 30835576
    [No Abstract]   [Full Text] [Related]  

  • 9. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature.
    Thomas JE; Munir JA; McIntyre PZ; Ferguson MA
    Tex Heart Inst J; 2009; 36(6):586-90. PubMed ID: 20069086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synephrine is not Neo-Synephrine.
    Bouchard N; Hoffman RS
    Mayo Clin Proc; 2004 Dec; 79(12):1589-90; author reply 1590; discussion 1590. PubMed ID: 15595351
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
    Stohs SJ
    Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Citrus aurantium (bitter orange) fruit extracts and p-synephrine on metabolic fluxes in the rat liver.
    Peixoto JS; Comar JF; Moreira CT; Soares AA; de Oliveira AL; Bracht A; Peralta RM
    Molecules; 2012 May; 17(5):5854-69. PubMed ID: 22592089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Ephedra-free" diet pill-induced psychosis.
    Retamero C; Rivera T; Murphy K
    Psychosomatics; 2011; 52(6):579-82. PubMed ID: 22054631
    [No Abstract]   [Full Text] [Related]  

  • 14. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium).
    Nelson BC; Putzbach K; Sharpless KE; Sander LC
    J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study.
    Shara M; Stohs SJ; Smadi MM
    Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk assessment of synephrine in dietary supplements].
    Bakhyia N; Dusemund B; Richter K; Lindtner O; Hirsch-Ernst KI; Schäfer B; Lampen A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):323-331. PubMed ID: 28058460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse Takotsubo cardiomyopathy in the setting of anaphylaxis treated with high-dose intravenous epinephrine.
    Khoueiry G; Abi Rafeh N; Azab B; Markman E; Waked A; AbouRjaili G; Shariff M; Costantino T
    J Emerg Med; 2013 Jan; 44(1):96-9. PubMed ID: 22595633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrus aurantium--beware of the bitter orange.
    Louw VJ; Louw H
    S Afr Med J; 2008 Jul; 98(7):496. PubMed ID: 18785379
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans.
    Seifert JG; Nelson A; Devonish J; Burke ER; Stohs SJ
    Int J Med Sci; 2011 Mar; 8(3):192-7. PubMed ID: 21448304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.